Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bienaime Jean Jacques
Relationship:  
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   8    
Direct Shares   540,054    

Indirect Shares

   247,533      
Direct Value   $43,092,104    

Indirect Value

   $21,938,850      
Total Shares   787,587      
Total Value   $65,030,954      


Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,125 Incyte Corp $914,552 Immunome Inc. $149,513 Keros Therapeutics, Inc. $0 Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,125 Incyte Corp $914,552 Immunome Inc. $149,513 Keros Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    2   
    1    

     Stock price went up :
    1   
    0    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
   -13.1%
 -5.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Director 2024-05-20 473,792 2024-05-20 247,533    Premium*  
            Neurogesx Inc NGSX Director 2011-07-26 21,748 0    Premium*  
            InterMune Inc ITMN Director 2014-09-29 0 2012-04-06 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2014-05-16 706 2013-05-28 0    Premium*  
            Immunic Inc IMUX Director 2018-09-24 18,500 2001-04-23 0    Premium*  
            Incyte Corp INCY Director 2023-06-14 15,493 0    Premium*  
            Immunome Inc. IMNM 2024-05-21 9,615 0    Premium*  
            Keros Therapeutics, Inc. KROS 2024-06-01 200 0    Premium*  
* Premium Members only  

Records found :    853         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 30 of 35
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-11-16 4 OE $17.54 $730,892 D/D 41,670 365,038 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-09-15 4 OE $17.33 $737,859 D/D 42,577 421,161 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-04-18 4 OE $37.46 $749,200 D/D 20,000 354,983 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-04-28 4 OE $37.46 $749,200 D/D 20,000 354,983 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-05-06 4 OE $37.46 $749,200 D/D 20,000 355,324 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-04-27 4 AS $34.66 $769,872 D/D (22,000) 112,093 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-11-22 4 AS $77.60 $776,000 D/D (10,000) 327,080 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-05-05 4 OE $12.99 $779,400 I/I 60,000 20,000 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-04-22 4 AS $78.91 $789,100 D/D (10,000) 302,498 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-04-09 4 AS $79.06 $790,600 D/D (10,000) 298,213 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-04-23 4 AS $79.34 $793,400 D/D (10,000) 302,498 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-06-04 4 D $120.46 $799,854 D/D (6,640) 229,254 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-05-05 4 OE $80.15 $801,489 I/I 10,000 0 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-03-03 4 D $89.57 $805,145 D/D (8,989) 331,511 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2008-02-29 4 S $37.91 $805,798 D/D (21,142) 4,071 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-04-24 4 AS $82.29 $822,887 D/D (10,000) 290,031 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-05-10 4 AS $82.52 $825,193 D/D (10,000) 326,520 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-04-23 4 AS $82.58 $825,811 D/D (10,000) 290,031 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-03-15 4 D $87.74 $828,002 D/D (9,437) 514,519 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-02-03 4 AS $83.50 $835,000 D/D (10,000) 328,530 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-04-20 4 AS $83.65 $836,458 D/D (10,000) 290,031 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-04-14 4 AS $83.66 $836,600 D/D (10,000) 334,983 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-05-05 4 AS $84.14 $841,400 D/D (10,000) 335,324 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-03-01 4 AS $84.22 $842,769 D/D (10,000) 340,500 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-03-03 4 D $93.95 $844,517 D/D (8,989) 206,364 0 -
  853  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30  31   32   33   34   35      
  Page 30 of 35  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us